JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹26 Cr | ₹18 Cr | ₹8.49 Cr | ₹4.49 Cr | ₹1.88 Cr |
What is the latest Total Non-Current Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹8.49 Cr |
| Mar2022 | ₹4.49 Cr |
| Mar2021 | ₹1.88 Cr |
How is Total Non-Current Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 43.46 | |
| Mar2024 | ₹18 Cr | 113.41 | |
| Mar2023 | ₹8.49 Cr | 88.81 | |
| Mar2022 | ₹4.49 Cr | 139.42 | |
| Mar2021 | ₹1.88 Cr | - | |
Compare Total Non-Current Liabilities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,334.7 Cr | -5.5% | -8.8% | -13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,370.0 Cr | 1.2% | 5.5% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,802.0 Cr | -1.8% | -3.1% | 8.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹125,841.0 Cr | -2% | 2.8% | 19.2% | Stock Analytics | |
| CIPLA | ₹121,481.0 Cr | -0.7% | -8.6% | 2.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,220.0 Cr | -1.5% | -4.3% | 2.5% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -5.5% |
-8.8% |
-13% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses